Event-driven research including merger arbitrage and spin-offs. Subscribe for free to receive our montly "Buyback Wednesdays" and "C-Suite Transitions" articles
Mar 26, 2022 • 11 tweets • 3 min read
TOP 5 INSIDER PURCHASES for MARCH 25, 2022
ORIC Pharmaceuticals, Inc. $ORIC $4.54
HEICO Corporation $HEI $154.56
Clene Inc. $CLNN $3.02
Eastman Kodak Company $KODK $6.56
Oxford Square Capital Corp. $OXSQ $4.09
Here are the Insiders that made it to the Top 5 purchases!
🧵⬇️
1. President and CEO Jacob Chacko acquired 350,000 shares of ORIC Pharmaceuticals $ORIC, a biotech company, paying $4.92 per share for a total amount of $1.72 million. insidearbitrage.com/symbol-metrics…
Mar 25, 2022 • 14 tweets • 4 min read
TOP 5 INSIDER PURCHASES For MARCH 24, 2022
The top 5 purchases for March 24, 2022 included a third purchase for $GME this week and purchases for $GWRS
Ligand $LGND to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II $AHPA
$LGND bit.ly/3iyq4AV businesswire.com/news/home/2022…
On Nov 9, 2021 Ligand Pharmaceuticals $LGND announced it is pursuing plans to split Ligand into two separate, publicly traded companies with one featuring the OmniAb business bit.ly/3JRDSCV